Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Catherine Monteleone"'
Publikováno v:
Clinical and Experimental Emergency Medicine, Vol 11, Iss 1, Pp 94-99 (2024)
Approximately 0.7% of patients taking angiotensin-converting enzyme inhibitors (ACEIs) develop ACEI-induced angioedema (ACEI-IA). With no approved treatments for ACEI-IA, the risk of complications is concerning. Tranexamic acid (TXA) has the potentia
Externí odkaz:
https://doaj.org/article/520b06df20bf440a9b2fcec2672b2065
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1244-1247
Introduction Pomalidomide is an immunomodulating agent that is used to treat relapsed and/or refractory multiple myeloma. Although the incidence of hypersensitivity with pomalidomide is not well documented, the most common type of hypersensitivity in
Publikováno v:
Seizure. 71:270-278
This article provides an overview of the pathogenesis and risk factors associated with antiepileptic drug (AED) hypersensitivity reactions, provides prescribing guidelines that may minimize the risk of antiepileptic induced rashes, and discusses trea
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB7
Publikováno v:
Pituitary. 15:68-71
Octreotide is widely used as medical therapy for acromegaly. It is known to markedly reduce growth hormone levels, improve symptoms and reduce tumor size. Common side effects include gastrointestinal symptoms, hepatobiliary disorders, dizziness, head
Autor:
Sima Mithani, Catherine Monteleone
Publikováno v:
Journal of Asthma & Allergy Educators. 2:130-134
The objective was to investigate characteristics of patients using alternative therapies for asthma, reasons for its use and its association with conventional medicine use. Over a period of 14 months, 32 (18%) of 187 patients completing a survey repo
Publikováno v:
The journal of allergy and clinical immunology. In practice. 3(5)
Publikováno v:
Journal of Clinical Urology. 7:61-62
Publikováno v:
Southern Medical Journal. 103:260-261
Multiple myeloma is a plasma cell malignancy that classically presents with bone pain secondary to osteolytic lesions, anemia, and renal insufficiency. A 49-year-old man presented for workup of possible primary immunodeficiency due to a history of re